| __timestamp | Amicus Therapeutics, Inc. | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 20717000 | 7751000 |
| Thursday, January 1, 2015 | 47269000 | 10251000 |
| Friday, January 1, 2016 | 71151000 | 9575000 |
| Sunday, January 1, 2017 | 88671000 | 10912000 |
| Monday, January 1, 2018 | 127200000 | 11049000 |
| Tuesday, January 1, 2019 | 169861000 | 11646000 |
| Wednesday, January 1, 2020 | 156407000 | 13265000 |
| Friday, January 1, 2021 | 192710000 | 25805000 |
| Saturday, January 1, 2022 | 213041000 | 35182000 |
| Sunday, January 1, 2023 | 275270000 | 94999000 |
Unleashing insights
In the competitive world of biotechnology, managing operational expenses is crucial for success. This analysis compares the Selling, General, and Administrative (SG&A) expenses of Amicus Therapeutics, Inc. and Viridian Therapeutics, Inc. over a decade, from 2014 to 2023.
Amicus Therapeutics has seen a significant increase in SG&A expenses, growing by over 1,200% from 2014 to 2023. This reflects their aggressive expansion and investment in operational capabilities. In contrast, Viridian Therapeutics, while also experiencing growth, has maintained a more conservative increase of approximately 1,200% over the same period.
The data highlights a strategic divergence: Amicus's higher expenses suggest a focus on scaling operations, while Viridian's steadier growth may indicate a more cautious approach. Understanding these trends provides valuable insights into each company's strategic priorities and operational efficiency.
Selling, General, and Administrative Costs: Alnylam Pharmaceuticals, Inc. vs Viridian Therapeutics, Inc.
Intra-Cellular Therapies, Inc. and Amicus Therapeutics, Inc.: SG&A Spending Patterns Compared
Bio-Techne Corporation or Amicus Therapeutics, Inc.: Who Manages SG&A Costs Better?
Madrigal Pharmaceuticals, Inc. or Viridian Therapeutics, Inc.: Who Manages SG&A Costs Better?
Rhythm Pharmaceuticals, Inc. and Viridian Therapeutics, Inc.: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing PTC Therapeutics, Inc. and Amicus Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of MorphoSys AG and Amicus Therapeutics, Inc.
Amicus Therapeutics, Inc. and Soleno Therapeutics, Inc.: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Amicus Therapeutics, Inc. and Iovance Biotherapeutics, Inc.
Research and Development Investment: Amicus Therapeutics, Inc. vs Viridian Therapeutics, Inc.
Who Optimizes SG&A Costs Better? ImmunityBio, Inc. or Viridian Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Agios Pharmaceuticals, Inc. and Viridian Therapeutics, Inc.